EKF Diagnostics (LON:EKF) Shares Cross Above 200 Day Moving Average of $28.40

EKF Diagnostics Holdings plc (LON:EKF) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 28.40 ($0.35) and traded as high as GBX 28.43 ($0.35). EKF Diagnostics shares last traded at GBX 27.25 ($0.34), with a volume of 102,579 shares trading hands.

EKF Diagnostics Trading Down 1.1 %

The stock has a 50 day moving average price of GBX 27.45 and a 200 day moving average price of GBX 28.40. The company has a market cap of £123.64 million, a PE ratio of 2,725.00 and a beta of 0.58. The company has a current ratio of 2.69, a quick ratio of 1.77 and a debt-to-equity ratio of 6.01.

Insider Buying and Selling at EKF Diagnostics

In related news, insider Christopher H. B. Mills acquired 100,000 shares of the stock in a transaction on Friday, March 22nd. The stock was acquired at an average price of GBX 26 ($0.32) per share, for a total transaction of £26,000 ($32,366.49). 5.11% of the stock is owned by company insiders.

EKF Diagnostics Company Profile

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.